Skip to main content
. Author manuscript; available in PMC: 2011 Mar 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2010 Mar 1;53(3):415–416. doi: 10.1097/QAI.0b013e3181ba3e4e

Table 1.

Percent of participants with undetectable viral load (at 12 months).

Adherence VAS-month
% (n)
1-mo % missed
% (n)
1-week % missed
% (n)
ACTG 4-day
% (n)
≥ 95 % 78 % (131) 76 % (141) 77 % (131) 75 % (136)
< 95 % 47 % (16) 35 % (6) 50 % (16) 52 % (11)
χ2(1) = 13.14,
P = 0.001
χ2(1) = 12.80,
P = 0.001
χ2(1) = 9.55,
P < 0.01
χ2(1) = 4.71,
P < 0.05

VAS=Visual Analogue Scale of adherence

ACTG 4-day= adherence in the last four days